Nav: Home

Clue to cause of Alzheimer's dementia found in brain samples

October 22, 2012

Researchers at Washington University School of Medicine in St. Louis have found a key difference in the brains of people with Alzheimer's disease and those who are cognitively normal but still have brain plaques that characterize this type of dementia.

"There is a very interesting group of people whose thinking and memory are normal, even late in life, yet their brains are full of amyloid beta plaques that appear to be identical to what's seen in Alzheimer's disease," says David L. Brody, MD, PhD, associate professor of neurology. "How this can occur is a tantalizing clinical question. It makes it clear that we don't understand exactly what causes dementia."

Hard plaques made of a protein called amyloid beta are always present in the brain of a person diagnosed with Alzheimer's disease, according to Brody. But the simple presence of plaques does not always result in impaired thinking and memory. In other words, the plaques are necessary - but not sufficient - to cause Alzheimer's dementia.

The new study, available online in Annals of Neurology, still implicates amyloid beta in causing Alzheimer's dementia, but not necessarily in the form of plaques. Instead, smaller molecules of amyloid beta dissolved in the brain fluid appear more closely correlated with whether a person develops symptoms of dementia. Called amyloid beta "oligomers," they contain more than a single molecule of amyloid beta but not so many that they form a plaque.

Oligomers floating in brain fluid have long been suspected to have a role in Alzheimer's disease. But they are difficult to measure. Most methods only detect their presence or absence, or very large quantities. Brody and his colleagues developed a sensitive method to count even small numbers of oligomers in brain fluid and used it to compare amounts in their samples.

The researchers examined samples of brain tissue and fluid from 33 deceased elderly subjects (ages 74 to 107). Ten subjects were normal - no plaques and no dementia. Fourteen had plaques, but no dementia. And nine had a diagnosis of Alzheimer's disease - both plaques and dementia.

They found that cognitively normal patients with plaques and Alzheimer's patients both had the same amount of plaque, but the Alzheimer's patients had much higher oligomer levels.

But even oligomer levels did not completely distinguish the two groups. For example, some people with plaques but without dementia still had oligomers, even in similar quantity to some patients with Alzheimer's disease. Where the two groups differed completely, according to Brody and his colleagues, was the ratio of oligomers to plaques. They measured more oligomers per plaque in patients with dementia, and fewer oligomers per plaque in the samples from cognitively normal people.

In people with plaques but no dementia, Brody speculates that the plaques could serve as a buffer, binding with free oligomers and keeping them tied down. And in dementia, perhaps the plaques have exceeded their capacity to capture the oligomers, leaving them free to float in the brain's fluid, where they can damage or interfere with neurons.

Brody cautions that, due to the difficulty in getting samples, oligomer levels have never been measured in living people. Therefore, it's possible these floating clumps of amyloid beta only form after death. Even so, he says, there is still a clear difference between the two groups.

"The plaques and oligomers appear to be in some kind of equilibrium," Brody says. "What happens to shift the relationship between the oligomers and plaques? Like much Alzheimer's research, this study raises more questions than it answers. But it's an important next piece of the puzzle."
-end-
Esparza TJ, Zhao H, Cirrito JR, Cairns NJ, Bateman RJ, Holtzman DM, Brody DL. Amyloid-beta oligomerization in Alzheimer dementia versus high-pathology controls. Annals of Neurology. Accepted Article, Online Sept. 1, 2012.

This study was supported by the National Institutes of Health (NIH), a Burroughs Wellcome Career Award in the Biomedical Sciences, the Thrasher Research Fund, the National Institute on Aging, the Charles F. and Joanne Knight Alzheimer's Disease Research Center at Washington University, the Cure Alzheimer's Fund, and the NIH Neuroscience Blueprint Core Grant to Washington University. Grant numbers: NIH R01 NS065069, NIH K08 NS049237, NIH AG13956, NIH AG029524, NIH K-23-AG03094601, NIH R-01-NS065667, NIH P50-AG05681, NIH P30 NS057105, and NIH P01-AG03991. Human brain and CSF samples were provided by the Washington University Knight Alzheimer's Disease Research Center.

Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient care institutions in the nation, currently ranked sixth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.

Washington University School of Medicine

Related Dementia Articles:

Latest issue of Alzheimer's & Dementia
Predicting heart disease might also be a warning sign for Alzheimer's; A new way to think about the environment and Alzheimer's research; Most dementia patients don't receive care from physicians who specialize in brain health.
What multilingual nuns can tell us about dementia
A strong ability in languages may help reduce the risk of developing dementia, says a new University of Waterloo study.
Brain changes may help track dementia, even before diagnosis
Even before a dementia diagnosis, people with mild cognitive impairment may have different changes in the brain depending on what type of dementia they have, according to a study published in the September 11, 2019, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Could marriage stave off dementia?
Dementia and marital status could be linked, according to a new Michigan State University study that found married people are less likely to experience dementia as they age.
Migraine diagnoses positively associated with all-cause dementia
Several studies have recently focused on the association between migraine headaches and other headaches and dementia and found a positive migraine-dementia relationship.
Apathy: The forgotten symptom of dementia
Apathy is the most common neuropsychiatric symptom of dementia, with a bigger impact on function than memory loss -- yet it is under-researched and often forgotten in care.
Dementia looks different in brains of Hispanics
A major new study from the UC Davis Alzheimer's Center has uncovered dramatic differences in the brains of Hispanics with a dementia diagnosis compared with those of non-Hispanic whites and of African Americans.
No association between antiepileptic drug use and dementia
Epilepsy is a common neurological condition with a prevalence of around 2 percent.
Correlation of stroke and dementia with death: A study from the Swedish dementia registry
Patients who died of IS the most common type of dementia was vascular dementia while those died from other causes were most often diagnosed with Alzheimer's dementia (AD).
Military risk factors for dementia
In recent years, there has been growing discussion to better understand the pathophysiological mechanisms of traumatic brain injury and post-traumatic stress disorder and how they may be linked to an increased risk of neurodegenerative diseases including Alzheimer's disease in veterans.
More Dementia News and Dementia Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.